Pazopanib and pancreatic toxicity: a case report

BACKGROUND: Pazopanib is an oral multitargeted tyrosine-kinase inhibitor, used as a single agent to treat advanced renal cell carcinoma. Treatment with other tyrosine-kinase inhibitors is known to be associated with asymptomatic elevations of serum amylase and lipase levels. As regards the pazopanib...

Descripción completa

Detalles Bibliográficos
Autores principales: Russano, Marco, Vincenzi, Bruno, Venditti, Olga, D’Onofrio, Loretta, Ratta, Raffaele, Guida, Francesco M., Tonini, Giuseppe, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434851/
https://www.ncbi.nlm.nih.gov/pubmed/25967382
http://dx.doi.org/10.1186/s13104-015-1154-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434851/
https://www.ncbi.nlm.nih.gov/pubmed/25967382
http://dx.doi.org/10.1186/s13104-015-1154-4

Ejemplares similares